DuPont de Nemours Inc vs Marvell Technology Inc — how do they compare? DuPont de Nemours Inc trades at $131.75 (market cap $17.70B), while Marvell Technology Inc trades at $279.4 (market cap $255.84B). The key difference: Marvell Technology Inc is far larger — about 14.5× DuPont de Nemours Inc's market cap, and DuPont de Nemours Inc pays the higher dividend (1.83%). Which is the better fit depends on your goals — on Pluang, investors hold DuPont de Nemours Inc for 89 Days and Marvell Technology Inc for 42 Days on average.
| DD | MRVL | |
|---|---|---|
Market Cap | $17.70B | $255.84B |
Volume | 638,303 | 23,652,500 |
Sector | Basic Materials | Technology |
52-Week High | $154.59 | $316.43 |
52-Week Low | $92.49 | $73.73 |
Typical Hold Time | 89 Days | 42 Days |
Enterprise Value | $19.09B | $257.20B |
Dividend Yield | 1.83% | 0.08% |
Signals from Pluang's Aura AI — not financial advice
DuPont (DD) trades at $131.08, down 1.65% on the day, with neutral technical signals from moving averages and oscillators. The company shows mixed fundamentals with recent earnings beats but declining revenue from $12.4B in 2024 to $6.85B in 2025, resulting in a net loss of $779M. Analyst sentiment remains positive with 58.5% buy ratings, though the consensus price target of $95 suggests caution. Recent developments include new product launches in sugar separation technology and Tyvek innovations, alongside ongoing PFAS litigation settlements.
The outlook for DD hinges on margin recovery and growth in key sectors like healthcare and water technologies, but investors face risks from legal liabilities, volatile cash flows, and high P/E valuation. Institutional activity shows mixed signals with both position reductions and significant increases, reflecting uncertainty about near-term performance amid structural growth opportunities.
Marvell Technology (MRVL) trades at $284.68, down 0.81% on the day, amid strong bullish technical signals and robust analyst optimism. The stock has delivered consecutive earnings beats, with Q2 2026 EPS of $0.94 exceeding expectations, and is supported by a consensus price target of $327.86. Revenue growth is accelerating, driven by data center demand and custom AI chip deals, though valuation multiples remain elevated with a P/E of 94.26.
The outlook is positive, fueled by AI infrastructure investments and raised fiscal 2028 revenue guidance to $18 billion. Key risks include high valuation sensitivity, competitive pressures, and execution challenges in scaling custom chip production. Analyst consensus is strongly bullish, with 84% buy ratings, but investors should weigh growth prospects against premium pricing and market volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics and communication, automotive, construction, safety and protection, and water management industries. DuPont benefits from the ability to produce patented specialty chemicals that command pricing power. Noteworthy products include Kevlar, Tyvek, and Nomex have evolved over time to enable a wide range of applications across multiple industries.
Read more on DD →Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
Read more on MRVL →